By Drug Target Review2025-06-23T08:30:14
DenovAI has unveiled a powerful AI-driven protein design platform capable of creating new, functional synthetic proteins from scratch - marking a big step forward for drug discovery.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-07-04T10:05:58
Sponsored by Revvity
2023-04-12T15:15:18
Sponsored by Cellistic
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud